Market Cap
$7.3B
HQY
HEALTHEQUITY, INC.
$89.84 ▲ +0.53%
Prev close $89.37Market cap$7.3B
ConsensusStrong Buy
12-mo target$119.33 (+32.8%)
▲ Bullish
Analyst conviction 10/10
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)37 New Institutional Positions13 Institutional ExitsCongressional Activity (1) Software & IT
Snapshot
The big-picture read on HQY right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (95%)
Inst. Holders
50 funds
Inst. Value
$6.2B
Inst. Activity
37 buys / 13 sells
Insider Activity
$0.00 buy / $2.4M sell
Insider Net $
-$2.4M
Social Sentiment
67° Warm
SEC Reports
7
Press Releases
1
Congressional
2 trades
Price chart 30d -8.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 28, 2026 short_volume
Short Volume: HQY — 66.2% short (0.4M / 0.5M)
Short: 357,452 | Exempt: 24 | TRF Vol: 539,586 | Short Ratio: 66.2% | Off-exchange volume (dark pool
Sep 17, 2026 Insider
Aug 27, 2026 SEC Neeleman Stephen gifted 1,500 shares
FOUNDER AND VICE CHAIRMAN
HealthEquity reported Q2 FY2027 results with revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, a 3.9% beat vs. $1.
8-K — Impact 7/10
HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, beating consensus estimates of $
PRESS-RELEASE — Impact 7/10
Aug 25, 2026 Insider
DILLON ADRIAN T acquired via exercise 7,632 shares
Director @ $32.50 ($248.0K)
Aug 25, 2026 Insider
Aug 3, 2026 SEC DILLON ADRIAN T sold 6,300 shares
Director @ $104.47 ($658.2K)
HealthEquity announced its fiscal Q2 2027 earnings release date of August 27, 2026, and scheduled investor conferences.
PRESS-RELEASE — Impact 2/10
Jul 10, 2026 Congress
Gilbert Cisneros buy
$1,001 - $15,000 — House
Analyst ratings buy % +11.8%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
95% rate it Buy or better · 20 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 18, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Aug 31, 2026 | Deutsche Bank | MAINTAIN | Buy | 58% |
| Aug 28, 2026 | BTIG | REITERATE | Buy | 53% |
| Jul 24, 2026 | BTIG | MAINTAIN | Buy | 53% |
| Jun 3, 2026 | RBC Capital | REITERATE | Outperform | 55% |
| Jun 1, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| May 29, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| May 22, 2026 | Barrington Research | MAINTAIN | Outperform | 55% |
| Apr 9, 2026 | BMO Capital | UPGRADE | Outperform | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 7 | 12 | 1 | 0 | 0 | 95% | |
| Aug 1, 2026 | 7 | 12 | 1 | 0 | 0 | 95% | |
| Jul 1, 2026 | 7 | 11 | 1 | 1 | 0 | 90% | |
| Jun 1, 2026 | 7 | 11 | 1 | 1 | 0 | 90% | |
| May 1, 2026 | 7 | 11 | 1 | 1 | 0 | 90% | |
| Apr 1, 2026 | 7 | 10 | 2 | 1 | 0 | 85% | |
| Mar 1, 2026 | 7 | 10 | 2 | 1 | 0 | 85% | |
| Feb 1, 2026 | 7 | 10 | 2 | 1 | 0 | 85% |
Price targets
Where 15 covering analysts think HQY trades over the next 12 months.
$119.33 +32.8% upside Strong Buy
Current$89.84 Low$105.00 Median$120.00 High$142.00 15 analysts
$105.00$142.00
Analyst rating Strong Buy· 1.3/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
67°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 3 bullish, 0 bearish, 2 mixed, 2 neutral · avg impact 5.1/10.Plus 1 press releases.
BULLISH8-K7/10
HealthEquity reported Q2 FY2027 results with revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24,
Aug 27, 2026
BULLISHPRESS-RELEASE7/10
HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, beating cons
Aug 27, 2026
NEUTRALPRESS-RELEASE2/10
HealthEquity announced its fiscal Q2 2027 earnings release date of August 27, 2026, and scheduled in
Aug 3, 2026
BULLISH8-K7/10
HealthEquity (HQY) reported FQ1 2026 revenue of $354.6M (+7% YoY) and non-GAAP EPS of $1.24, beating
Jun 5, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 28, 2026
short_volume
Short Volume: HQY — 66.2% short (0.4M / 0.5M)
Short: 357,452 | Exempt: 24 | TRF Vol: 539,586 | Short Ratio: 66.2% | Off-exchange volume (dark pool + OTC)
Aug 28, 2026
short_volume
Short Volume: HQY — 71.3% short (0.7M / 1.0M)
Short: 730,026 | Exempt: 9,259 | TRF Vol: 1,023,564 | Short Ratio: 71.3% | Off-exchange volume (dark pool + OTC)
Aug 27, 2026
earnings
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
Highlights of the second quarter include:
Aug 27, 2026
earnings_calendar
HQY Q2 2027 Earnings Scheduled — 2026-08-27
Aug 27, 2026
short_volume
Short Volume: HQY — 63.9% short (1.0M / 1.6M)
Short: 1,025,970 | Exempt: 50,516 | TRF Vol: 1,605,870 | Short Ratio: 63.9% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.15 | $1.13–$1.19 | 13.9% | -0.2% | 4↑ 5↓ | $0.3B | 14 |
| Next Q | $1.10 | $1.05–$1.16 | 16.1% | -2.6% | 1↑ 12↓ | $0.4B | 14 |
| Current FY | $4.72 | $4.70–$4.76 | 18.1% | +0.1% | 5↑ 2↓ | $1.4B | 14 |
| Next FY | $5.50 | $5.25–$6.01 | 16.4% | +1.0% | 5↑ 4↓ | $1.5B | 14 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.150 | — |
| 7d ago | $1.150 | — |
| 30d ago | $1.153 | -0.002 |
| 60d ago | $1.153 | -0.002 |
| 90d ago | $1.158 | -0.008 |
Institutional ownership
Which big funds own HQY (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $6.2B total value (69,038,337 shares) as of 2026-Q2. Top holders: BlackRock,, WASATCH, MORGAN. Net buying activity: 37 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 11,277,914 | $1.0B | 16.4% | — |
| WASATCH ADVISORS LP | 7,960,735 | $719.0M | 11.5% | — |
| MORGAN STANLEY | 4,547,219 | $410.7M | 6.6% | ADD +82.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,057,643 | $366.5M | 5.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,640,776 | $328.8M | 5.3% | — |
| STATE STREET CORP | 3,241,046 | $292.7M | 4.7% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 2,374,467 | $214.5M | 3.4% | — |
| AQR CAPITAL MANAGEMENT LLC | 1,999,209 | $176.1M | 2.8% | — |
| DIMENSIONAL FUND ADVISORS LP | 1,869,036 | $168.8M | 2.7% | — |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,773,227 | $160.2M | 2.6% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 2,485,913 | 4,547,219 | +82.9% | $410.7M |
| FMR LLC | ADD | 1,134,933 | 1,538,387 | +35.5% | $138.9M |
| BANK OF AMERICA CORP /DE/ | ADD | 862,008 | 1,146,735 | +33.0% | $103.6M |
| GOLDMAN SACHS GROUP INC | ADD | 800,818 | 1,007,434 | +25.8% | $91.0M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 2,781 | 965,807 | +34628.8% | $87.2M |
| CITADEL ADVISORS LLC | DOUBLED | 268,832 | 682,961 | +154.0% | $61.7M |
| NORGES BANK | NEW | — | 533,946 | — | $48.2M |
| UBS Group AG | TRIM | 786,667 | 435,457 | -44.6% | $39.3M |
| Artisan Partners Limited Partnership | ADD | 270,942 | 384,107 | +41.8% | $34.7M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 808,867 | 249,975 | -69.1% | $22.6M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 45 transactions. Net -$2.4M — $0.00 bought, $2.4M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Neeleman Stephen | FOUNDER AND VICE CHAIRMAN | GIFT | 1,500 | — | — |
| Aug 25, 2026 | DILLON ADRIAN T | Director | EXERCISE | 7,632 | $32.50 | $248.0K |
| Aug 25, 2026 | DILLON ADRIAN T | Director | SELL | 6,300 | $104.47 | $658.2K |
| Aug 25, 2026 | DILLON ADRIAN T | Director | SELL | 1,332 | $105.26 | $140.2K |
| Jul 10, 2026 | Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER | SELL | 2,354 | $95.00 | $223.6K |
| Jul 9, 2026 | Gathright Michael | Chief Customer Officer | TAX W/H | 2,270 | $93.07 | $211.3K |
| Jul 8, 2026 | Cutler Scott | President and CEO | TAX W/H | 1,238 | $95.08 | $117.7K |
| Jul 8, 2026 | Neeleman Stephen | FOUNDER AND VICE CHAIRMAN | TAX W/H | 1,103 | $95.08 | $104.9K |
| Jul 8, 2026 | Lucania James M | EVP & CFO | TAX W/H | 2,839 | $95.08 | $269.9K |
| Jul 8, 2026 | Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER | TAX W/H | 2,045 | $95.08 | $194.4K |
Congressional trades
HQY trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 0 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | HealthEquity Inc | Sep 7, 2026(60d) |
| Jun 30, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | HealthEquity Inc | Jul 3, 2026(4d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for HQY.
Shares short
4,801,056
Settlement Sep 15, 2026
Change vs prior
+6.3%
Semi-monthly cycle
Days to cover
6.4
At avg daily volume
Of shares outstanding
≈5.8%
Estimate — not % of float
All HQY filing & press-release reports (8)
- 8-K reportAug 27, 2026
- PRESS-RELEASE reportAug 27, 2026
- PRESS-RELEASE reportAug 3, 2026
- 8-K reportJun 5, 2026
- CLUSTER reportJun 2, 2026
- PRESS-RELEASE reportMay 28, 2026
- 8-K reportMay 8, 2026
- PRESS-RELEASE reportMar 17, 2026